← All Sponsors
SPONSOR

Gan and Lee Pharmaceuticals, USA

Total Trials
2
Recruiting
2
Phases
Phase 2, Phase 1
Conditions studied: Type 2 DiabetesHealthy Subjects
NCT06558708 Phase 2
Recruiting

A Trial Comparing Efficacy, Tolerability, and Safety of GZR101 Injection Once Daily (OD) and GZR33-70 Injection OD

Type 2 Diabetes
China View Trial →
NCT06548906 Phase 1
Recruiting

A Study of GZR4 Injection at Different Injection Sites

Healthy Subjects
China View Trial →